All the Active Ingredient Drugs
Estrogen, Progestogen. Drospirenone 3 mg, Ethynilestradiol 0.03 mg. TABS: 1 x 21, 3 x 21. 1 tab. dly at the
same time for 21 days foll. by 7 days tab
free. See lit.
C/I: Current or hist. of VTE or pulm. embol. ,
Known hereditary or acquired predispose.
for VTE such as APC resistance, (includ.
Factor V Leiden), antithrombin-III-defic.,
protein C defic., protein S defic., major
surgery with prolon. immobilization., A
high risk of VTE due to the of multiple risk
factors, current or history of ATE(e.g. MI) or
prodromal condition (e.g. angina pectoris),
current stroke, history of stroke or
prodromal condition (e.g. TIA, Known
hereditary or acquir. predispose. for ATE,
such as hyperhomocysteinaemia and
anticoag.), History of migraine with focal neurology. sympt, A high risk of ATE due to
multiple risk factors or to the presence of
one serious risk factor such as: diabetes
mell.with vasc.sympt., Severe HTN, Severe
dyslipoproteinaemia, Presence/ hist. of
severe hepatic dis., Severe renal insuff. or
acute ren. fail Presence or hist. of liver
tumours (benign or malig.), Known or
suspected sex-steroid influenced
malignancies (e.g. of the genital organs or
the breasts), Undiagnosed vag. bleed.
Natural and Semisynthetic Estrogens. Drospirenone 3 mg, Ethinylestradiol (as betadex calthrate) 0.03 mg, Levomefolate Calcium 0.451 mg. F.C TABS: 1, 3, 6 X 28. Take once dly. for 28 consec. days in order direct. in pack. See lit.
Oral contracept. In women who choose to use an oral contracept. as their method of contracept., to raise folate levels for reducing risk of a neural tube defect in a pregn. conceived while taking the product
or shortly after discontin. the product.
C/I: Renal impair., adrenal insuff., high risk of arterial/ ven. thromb.dis. [e.g. women who Smoke, age> 35, have DVT or pulm. embolism, now or in the past., cerebrovasc. dis., coron. art.dis., thrombogenic valvul./ or thrombogenic rhythm dis. of the heart (e.g. subacute bact. endocardit. with valvul. dis., or AF), inherited or acquired hypercoagulopathies, uncontrol. HTN, diabetes mell. with vasc. dis., headaches with focal neurological sympt. or have migraine headaches with or without aura if over age 35, Undiagnosed abnor. uterine bleed.]. Breast cancer or other estrogen- or progestinsensitive cancer, now or in the past, Liver tumor (benign or malig.), liver dis., Preg.
Natural and Semisynthetic Estrogens. Drospirenone 3 mg, Ethinylestradiol 0.02 mg, Levomefolate Calcium 0.451 mg. F.C. TABS.:28. 1 tab×1/d at same time
every day. See lit.
Oral contracep. Tmt. of sympt. of PMDD in
women who choose to use an oral
contracep. as their method of birth control.
Tmt. of moder.acne vulgaris in women at
least 14 yrs. of age, who have no known
contraind. to oral contracep. ther.and have
achieved menarche. In women who choose
to use an oral contracep. as their method of
contracep., to raise folate levels for the
purpose of reduc. the risk of a neural tube
defect in a preg. conceived while taking the
product or shortly after discount. the
C/I: Renal impair. Adrenal insuff. A high
risk of arter./ven. thromb. dis. Examp.
include. women who are known to:
Smoke, if over age 35. DVT or pulm.
embol., now or in the past. Have CV dis.
Coron. artery dis. Thromb. valvular or
thromb. rhythm dis. of the heart (e.g.
subacute bact. endocardit. with valv. dis.,
or atr. fibril. Inherited or acquired
hypercoagulopathies. Uncont. hyperten.
Diabetes mell.with vasc. dis. Headaches
with focal neurology. sympt. or have
migraine headaches with/without aura if
over age 35. Undiagn. abnorm. uterine
bleed. Breast canc./ other estrogen- or
progestin-sensit. canc., now or in the past.
Liver tum., benign or malig., or liver dis.
Preg., because there is no reason to use
COCs during preg.